Intuitive Surgical Vs. Stryker: Wall Street Loves Both But One Has a Quiet Advantage That Will Make Investors Money

Impact · against what's priced in

The news is largely a confirmation of existing baselines for both companies, though Intuitive Surgical sees a modest positive catalyst from strong analyst conviction. Stryker's updates regarding its vascular supply chain and organic growth are already reflected in its current valuation.

SYK+0.00

Already priced in

The price assumes

MedSurg segment revenue growing near 9% organically